Skip to main content
Erschienen in: BMC Women's Health 1/2021

Open Access 01.12.2021 | Research article

Alleviating psychological distress associated with a positive cervical cancer screening result: a randomized control trial

verfasst von: Yukari Isaka, Ai Hori, Rie Tanaka, Masao Ichikawa

Erschienen in: BMC Women's Health | Ausgabe 1/2021

Abstract

Background

The method of communicating a positive cancer screening result should seek to alleviate psychological distress associated with a positive result. We evaluated whether the provision of information through a leaflet would help reduce psychological distress in a randomized controlled trial.

Methods

The participants were women aged 20–69 years who were about to undergo cervical cancer screening at health centers. Before the screening, they received hypothetical screening results, with a leaflet (intervention group, n = 493) or without it (control group, n = 479), randomly. Their psychological distress and intention to undergo further examination were then compared between the intervention and control groups.

Results

After the intervention (providing a leaflet with hypothetical screening results), psychological distress appeared to be higher in the control group than in the intervention group among those who received a hypothetical positive screening result (odds ratio: 2.57, 95% confidence interval: 1.87–3.54), while 95% and 97% of those in the intervention and control groups, respectively, reported that they would undergo further examination.

Conclusions

Information provision might help reduce psychological distress but not hinder further examination among women who screen positive for cervical cancer.
Trial registration: UMIN Clinical Trials Registry UMIN000029894. Date of Registration: November 2017.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
TBS
The Bethesda System
ORs
Odds ratios
CIs
Confidence intervals

Background

Globally, cervical cancer is the fourth most common cancer among women, with about 567,000 incident cases and about 311,000 deaths in 2018 [1]. In Japan, cervical cancer is the fourth most common cancer among women [2, 3]. The mortality rate (per 100,000 population) of cervical cancer in Japan was 2.7 in 2018, which was higher than the rates in other developed countries: 1.9 in the United States, 1.7 in the United Kingdom, 1.7 in Australia, and 1.7 Canada [4]. To enable early detection and treatment of cervical cancer, the Japanese government recommends that women aged 20–69 years undergo cytology-based (Pap smear) screening every two years [5].
While cervical cancer screening is largely beneficial for women, a positive screening result might cause psychological burden [6]. In fact, our previous study involving women who had undergone cervical cancer screening found a greater level of psychological distress among those who had received a positive result than those who had not yet received a result. However, the positive predictive value of Pap smear screening was only 1.9% in the Japanese population (i.e., only 2 in 100 women with a positive screening result are finally diagnosed with cervical cancer) [6, 7]. Psychological distress associated with a positive result should not be overlooked because a positive result can influence the decision to undergo further examination, future screening for cervical cancer, and daily activities [812].
Psychological distress due to a positive screening result might be mitigated if women are made aware of the fact that this result does not necessarily indicate a cancer diagnosis. A randomized controlled trial conducted in the United Kingdom suggested that the provision of such information through a leaflet when notifying women of a positive result could help avoid adverse psychological effects [13]. Thus, in the United Kingdom, women participating in cervical cancer screening programs receive a leaflet that is tailored to explain every part of the process, such as screening, normal results, abnormal results, and treatment [14, 15]. In Japan, such information is not provided to women undergoing cervical cancer screening; they are only informed of a positive or negative result, generally through a notification letter. In the case of several local governments, the abbreviations of the cytological stages are used to indicate the cytology results. This information is intended not for women but for physicians who conduct further examinations.
Women who screen positive need to undergo further examination, and their intention to do so might be influenced by the level of psychological distress they experience [16, 17]. Therefore, the information provided during the cervical cancer screening process should serve the purpose of prompting women with a positive result to undergo further examination while alleviating psychological distress. To date, these two outcomes of information provision have not been investigated at the same time. Therefore, we previously developed a leaflet to achieve these two goals. In the present study, we conducted a questionnaire-based randomized controlled trial to evaluate whether the leaflet would help reduce psychological distress without affecting the intention to undergo further examination among women who were about to undergo population-based screening for cervical cancer.

Methods

Study design

This study was a simple randomized controlled trial that randomly assigned individual participants to the intervention and control groups and measured outcomes before and after the intervention. The trial was approved by the Research Ethics Committee of the Faculty of Medicine at the University of Tsukuba (No.1216) and registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN000029894). We also obtained official permission from Tsukuba City to conduct the trial at the City’s health centers. This article complies with the Consolidated Standards of Reporting Trials 2010 guideline [18, 19].

Setting

We conducted this study in Tsukuba City, Ibaraki Prefecture, a semi-urban city located 50 km northeast of Tokyo, with a population of 237,000. In Japan, cancer screening is conducted as a health promotion service based on the Health Promotion Act. The local government introduced a population-based cervical cancer screening system in 1983. In 2001, the Research Group for Cancer Screening Guidelines commissioned by the Japanese government recommended the use of cytology-based screening for cervical cancer [5]. In Ibaraki Prefecture, women aged 20–69 years are invited to undergo cervical cancer screening every two years through a letter with a subsidized or free coupon. Those who undergo cervical cancer screening are informed of the results through a letter. In case of a positive result, the cytology result based on the Bethesda System (TBS; indicating the cytological stage) is included.

Participants

The participants were women aged 20–69 years who were about to undergo cervical cancer screening at health centers in Tsukuba City from July 2017 to February 2018. Those who were able to read and write Japanese were eligible to participate in the study. We selected two health centers where a large number of women underwent cervical cancer screening. The participants were recruited by health centers’ public health nurses at the reception of screening venues. They explained the aim of the study in written materials and provided written informed consent if they agreed to participate.
The sample size required for this study was 814 participants (407 each for the intervention and control groups) to ensure an 80% power and 5% significance level, and with an assumption that the prevalence of psychological distress among women who received a positive screening result was 50%, based on our previous findings, and that the intervention could reduce it to 40% [6].

Intervention

The provision of information through a leaflet was the intervention in this study. The leaflet contained basic information about cervical cancer and its screening, the advantages and disadvantages of screening (including information on false-positives, false-negatives, and overdiagnosis), purpose and validity of the screening/further examination, meaning and causes of a positive screening result, explanation of TBS [20], effectiveness of treatment, importance of undergoing further examination, and where to undergo further examination and how to make a reservation for it. We explicitly stated that a positive screening result does not indicate a cancer diagnosis.
To develop the leaflet, we first reviewed current screening result notification-related practices in Ibaraki Prefecture as well as the leaflets regarding cervical cancer screening developed by the National Cancer Center in the United States and the National Health Service in the United Kingdom [15]. Second, we conducted an individual interview and focus group discussion to understand exactly what information should be provided to women who undergo cervical cancer screening. For the interview, we invited 10 women aged 20–69 who visited the hospital to undergo further examination for cervical cancer in order to draft the leaflet. We then conducted two focus group discussions with a total of 12 women to make the necessary revisions of the drafted leaflet. For the focus group discussions, we recruited women aged 20–69 from the general population through advertisements. Finally, we checked the appropriateness of the leaflet with health professionals, including gynecologists.

Procedure and randomization

The participants received self-administered questionnaires that consisted of baseline questions, a hypothetical notification letter of cervical cancer screening, the leaflet (only for the intervention group), and follow-up questions. A hypothetical notification letter indicated a positive or negative result. In the case of a positive result, the letter indicated a hypothetical cytological stage, one of the five TBS-based grades, or no stage. Thus, there were six patterns of positive results, plus a negative result.
In baseline questions, the participants rated their psychological distress. They were then instructed to read the hypothetical notification letter as if they were being informed of the actual screening results. Those in the intervention group read the leaflet after the notification letter. Finally, all the participants rated their psychological distress again in the follow-up questions.
The leaflet was randomly included in the questionnaires that were consecutively handed to the participants as they came to health centers for the screening. The questionnaires were handed only to those who agreed to participate. This was the procedure of random allocation of the participants to the intervention and control groups. Since the intervention (leaflet) was known to the participants but not to the authors or public health nurses who handed the questionnaires, the trial was single-blinded.
The participants were requested to answer and return the questionnaire while waiting to undergo screening. As an ethical consideration, all the participants were provided with the leaflet when they returned the questionnaire. They were also allowed to consult with public health nurses during the screening or later by phone or e-mail, in cases where they became too worried about the screening results because of this study and they wished to consult. The participants received actual screening results from health centers by mail about two weeks after the screening.

Measurement

The primary outcome was cancer-related psychological distress. Psychological distress was measured using the Cancer Worry Scale [21, 22]. The Japanese version of this scale has been demonstrated to be valid in the context of breast cancer-related worry. In this study, we replaced “breast cancer” with “cervical cancer.” The scale consists of six items, five of which are measured on a four-point Likert scale, and one measured on a five-point Likert scale. The total score ranges from 6 to 25, with a score of 15 or higher indicating a significantly high degree of psychological distress. The secondary outcome was the intention to undergo further examination for cervical cancer, which was determined with a yes/no question.
The covariates measured included demographic characteristics, mental health, perceived health competence, and attitudes toward cervical cancer screening. Mental health was assessed using the Japanese version of the K6 scale, which was designed to measure depression and anxiety [23, 24]. The K6 scale consists of six items rated on a five-point Likert scale. The total score ranges from 0 to 24, with higher scores indicating higher degrees of depression and anxiety. Perceived health competence was measured using a Japanese version of the modified Perceived Health Competence Scale [25]. This tool, which measures self-efficacy regarding general health-related behaviors [26], contains eight items measured on a five-point Likert scale. The total score ranges from 8 to 40, with higher scores indicating higher degrees of self-efficacy. Attitudes toward cervical cancer screening were measured using a modified version of the 16-item Attitude toward Breast Cancer Screening Scale [21]. The items were measured on a five-point Likert scale. In this study, we replaced “breast cancer” in the original scale with “cervical cancer.” This scale includes four factors: barriers toward screening, lack of perceived importance of screening, perceptions of screening, and subjective norms related to screening. The score for each factor was calculated. The total score ranges from 4 to 20, with lower scores indicating better attitudes toward cervical cancer screening. The Japanese versions of the three scales mentioned above have been validated [21, 23, 25].

Statistical analysis

First, we compared the participants’ baseline characteristics between the intervention and control groups, and then calculated the proportion of psychological distress (i.e., Cancer Worry Scale score ≥ 15) among the participants before and after the intervention in the intervention and control groups by positive and negative screening results. To take into account psychological distress at baseline, the proportion of psychological distress after the intervention was also calculated specifically among participants without psychological distress before the intervention. Finally, we estimated the effect of the intervention with odds ratios (ORs) and 95% confidence intervals (CIs) by positive (each cytological grade) and negative screening results. All analyses were based on intention-to-treat.

Results

Figure 1 shows the flowchart of the participants. Of the 1540 women invited, 1133 participated in the study, 584 in the intervention group and 549 in the control group. We excluded those aged 70 years or older (15 and 6 participants in the intervention and control groups, respectively) and those with missing values for the outcome variables (76 and 64 participants in the intervention and control groups, respectively). Finally, 972 participants were included in the analysis: 493 in the intervention group and 479 in the control group.
Table 1 compares the participants’ characteristics between the intervention and control groups. The mean age of participants was 45 years. Most had graduated from junior college or university (79%), had a spouse/partner (90%), and had experienced childbirth at least once (87%). Regarding occupation, the participants mainly held either part-time jobs (40%) or were housewives (32%), and 25% of the participants had a smoking history. The mean K6 score was 3.1. Most (92%) of the participants had undergone cervical cancer screening in the past, but had mostly received negative results (90%). Only 6% had previously undergone further examination. There were no significant differences between the intervention and control groups with regard to general characteristics, perceived health competence, or attitudes toward screening.
Table 1
Comparison of participants’ characteristics
 
Intervention group n (%)
Control group n (%)
493 (50.7)
479 (49.3)
Age, years
Mean
44.6 (10.3)
44.9 (10.1)
 20–29
17 (3.5)
15 (3.1)
 30–39
153 (31.0)
133 (27.8)
 40–49
180 (36.5)
184 (38.4)
 50–59
75 (15.2)
75 (15.7)
 60–69
58 (11.8)
55 (11.5)
 Missing
10 (2.0)
17 (3.6)
Educational level
Junior high school
2 (0.4)
4 (0.8)
High school
82 (16.3)
104 (21.7)
Vocational school/junior college
191 (38.7)
184 (38.4)
College/university
214 (43.4)
183 (38.2)
Missing
4 (0.8)
4 (0.8)
Marital status
Married/partnered
441 (89.5)
428 (89.4)
Widowed/divorced
23 (4.7)
27 (5.6)
Single
28 (5.7)
22 (4.6)
Missing
1 (0.2)
2 (0.4)
Occupation
Public officer
87 (17.7)
73 (16.2)
Self-employed
26 (5.3)
21 (4.4)
Part-time job
189 (38.3)
203 (42.4)
Housewife
161 (32.7)
153 (31.9)
None
7 (1.4)
10 (2.1)
Student
8 (1.6)
5 (1.0)
Other
14 (2.8)
12 (2.5)
Missing
1 (0.2)
2 (0.4)
Smoker
At some point
111 (22.5)
128 (26.7)
Never
380 (77.1)
350 (73.1)
Missing
2 (0.4)
1 (0.2)
Childbirth experience
No
69 (14.0)
60 (87.1)
Yes
423 (85.8)
417 (87.1)
Missing
1 (0.2)
2 (0.4)
Diagnosed history of cancer
Yes
18 (3.7)
11 (2.3)
No
447 (90.7)
455 (95.0)
Missing
28 (5.7)
13 (2.7)
Mental health (K6)
Mean K6 score (SD)
3.2 (3.6)
3.0 (3.6)
Missing
11 (2.2)
8 (1.7)
History of cervical cancer screening
Yes
452 (91.7)
438 (91.4)
No
32 (6.5)
26 (5.4)
Missing
9 (1.8)
15 (3.1)
History of positive cervical cancer screening resulta
Yes
29 (6.4)
23 (5.3)
No
406 (89.8)
399 (91.1)
Don’t know
0 (0.0)
1 (0.2)
Missing
17 (3.8)
15 (3.4)
History of further examinationa
Yes
27 (6.0)
22 (5.0)
No
421 (93.1)
410 (93.6)
Missing
4 (0.9)
6 (1.7)
Perceived health competenceb
Mean (SD)
23.6 (3.0)
23.6 (3.0)
Attitude toward cervical cancer screeningb
Barriers toward screening
9.8 (3.7)
9.7 (3.4)
Lack of perceived importance of screening
7.0 (2.3)
7.1 (2.2)
Perceptions of screening
13.0 (3.2)
12.7 (3.0)
Subjective norms related to screening
10.6 (3.4)
10.7 (3.3)
SD standard deviation
aThe proportion of women with a history of positive cervical cancer screening results differs from other variables in the number of denominators. Among the women with a history of cervical cancer screening, this is the proportion with experience of positive results
bThe number is different because the score was calculated by excluding those with missing responses on the questionnaire
As shown in Table 2, the proportion of psychological distress (i.e., Cancer Worry Scale score ≥ 15) at baseline was not significantly different between the intervention and control groups. Among those who were informed of a positive result, this proportion increased more in the control group (from 47 to 79%) than in the intervention group (from 44 to 60%). The same trend was observed for the six positive result patterns. Among those who were informed of a negative screening result, this proportion did not increase in either the intervention or control group.
Table 2
Proportion of psychological distressa before and after receiving the hypothetical result in the intervention and control groups by screening results
 
Intervention group
Control group
 
Before
After
 
Before
After
Number
n (%)
n (%)
Number
n (%)
n (%)
Positive resultb
423
171 (43.7)
252 (59.6)
407
85 (46.9)
322 (79.1)
 ASC-US (Lowest grade)
73
32 (43.8)
49 (67.1)
67
29 (43.3)
52 (77.6)
 ASC-H
60
29 (48.3)
33 (55.0)
67
23 (34.3)
55 (82.1)
 LSIL
71
32 (45.1)
44 (62.0)
62
32 (51.6)
46 (74.2)
 HSIL
77
32 (41.6)
39 (50.7)
66
29 (43.9)
52 (78.8)
 SCC (Highest grade)
76
31 (40.8)
46 (60.5)
73
43 (58.9)
54 (74.0)
 Not informed of the cytological stages
66
29 (43.9)
41 (62.1)
72
35 (48.6)
63 (87.5)
Negative result
70
31 (44.3)
31 (44.3)
72
34 (47.2)
29 (40.3)
ASC-US, ASC-H, LSIL, HSIL, and SCC are abbreviations of the cytological stages
aThe total score ranges from 6 to 25, with higher scores indicating a higher degree of psychological distress. Participants with higher psychological distress scores received high cancer worry scores (≥ 15)
bAll six patterns of positive results
Among those without psychological distress at baseline, the proportion of psychological distress after being informed of a positive screening result appeared to be higher in the control group (64%) than in the intervention group (36%). This was not the case among the participants who were informed of a negative result (10% and 11% in the intervention and control groups, respectively) (data not shown).
After the intervention, among those who were informed of a positive screening result, psychological distress was higher in the control group than in the intervention group (OR: 2.57, 95% CI: 1.87–3.54), but this was not the case among those who were informed of a negative result (OR: 0.85, 95% CI: 0.41–1.74). Among those who were informed of a positive screening result, 95% and 97% of those in the intervention and control groups, respectively, reported that they would undergo further examination.

Discussion

We evaluated whether the provision of information through a leaflet would help reduce psychological distress without affecting the intention to undergo further examination among women undergoing cervical cancer screening. As a result, psychological distress appeared to be lower in the intervention group (women receiving a leaflet) than in the control group (women not receiving it) among those who received a hypothetical positive screening result at any cytological stage, while women in both groups maintained the intention to undergo further examination. Our findings suggest that, irrespective of cytological grade, the psychological distress associated with a positive cervical cancer screening result can be averted if these women receive the relevant information, which does not affect their intention to undergo further examination.
Generally, a positive screening result is ambiguous and worrisome to women who are not familiar with the process. Therefore, it is necessary to resolve this ambiguity to alleviate their concerns. Reportedly, the provision of simple but thorough information is useful in improving their understanding [27, 28]. Therefore, we clearly described the possibility of false positives, false negatives, and overdiagnosis in a leaflet. We also explicitly stated that a positive screening result is not a cancer diagnosis as well as specifying the benefits of screening.
While the provision of such information will be helpful for women to manage potential psychological distress associated with a positive screening result, it will not interfere with their intention to undergo further examination in case of a positive result. This is clinically important because the ultimate goal of screening is to enable early detection and treatment of the disease, which requires further examination of those who screen positive.
The policy implications of this study are the fact that a simple intervention of providing relevant information using leaflets can reduce cervical cancer-related psychological distress without affecting the intention to undergo further examination. This should be practically and financially feasible; the leaflets simply need to be sent with the letters containing the screening results.
Our study had several limitations. First, since the screening results were hypothetical, it is unclear whether such information provision would reduce psychological distress in actual situations. Yet, even in a hypothetical situation, the increase in psychological distress was greater among those who did not receive information. This result indicates the potential impact of information provision on psychological distress. Second, in the study setting, women might have read the leaflet more carefully than in a routine clinical setting. If this was the case, the alleviating effect of the leaflet on psychological distress might have been overestimated. On the other hand, their intention to undergo further examination was less likely to be affected because the proportion of the study participants who had such an intention was over 90%. According to the national cancer statistics, the proportion of women who actually received a positive result of cervical cancer screening and took further examination was about 80% [7]. Third, we need to be cautious about generalizing the findings because the participants of this study had a high educational level, with 79% having graduated from college/university, whereas only 30% of women nationwide have attained that level of education [29]. Therefore, it is necessary to investigate whether the message in the leaflet would be easily comprehensible to the majority of women undergoing cervical cancer screening.

Conclusions

In conclusion, information provision would help reduce psychological distress among women who receive a positive cervical cancer screening result without affecting their intention to undergo further examination. We recommend that cervical cancer screening programs provide participants with all relevant information.

Acknowledgements

Not applicable.
The study protocol was approved by the research ethics committee at the University of Tsukuba (No.1216) and registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN000029894). Written consent was obtained from all participants.
Not Applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018. GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018. GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.
2.
Zurück zum Zitat Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45(9):884–91. Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H; Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45(9):884–91.
5.
Zurück zum Zitat Hamashima C, Aoki D, Miyagi E, Saito E, Nakayama T, Sagawa M, Saito H, Sobue T; Japanese Research Group for Development of Cervical Cancer Screening Guidelines. The Japanese guideline for cervical cancer screening. Jpn J Clin Oncol. 2010;40:485–502. Hamashima C, Aoki D, Miyagi E, Saito E, Nakayama T, Sagawa M, Saito H, Sobue T; Japanese Research Group for Development of Cervical Cancer Screening Guidelines. The Japanese guideline for cervical cancer screening. Jpn J Clin Oncol. 2010;40:485–502.
6.
Zurück zum Zitat Isaka Y, Inada H, Hiranuma Y, Ichikawa M. Psychological impact of positive cervical cancer screening results among Japanese women. Int J Clin Oncol. 2017;22(1):102–6.CrossRef Isaka Y, Inada H, Hiranuma Y, Ichikawa M. Psychological impact of positive cervical cancer screening results among Japanese women. Int J Clin Oncol. 2017;22(1):102–6.CrossRef
8.
Zurück zum Zitat Gray NM, Sharp L, Cotton SC, Masson LF, Little J, Walker LG, Avis M, Philips Z, Russell I, Whynes D, Cruickshank M, Woolley CM; TOMBOLA Group. Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer. 2006:94:1253–62. Gray NM, Sharp L, Cotton SC, Masson LF, Little J, Walker LG, Avis M, Philips Z, Russell I, Whynes D, Cruickshank M, Woolley CM; TOMBOLA Group. Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer. 2006:94:1253–62.
9.
Zurück zum Zitat Hellsten C, Sjostrom K, Lindqvist PG. A 2-year follow-up study of anxiety and depression in women referred for colposcopy after an abnormal cervical smear. BJOG. 2008;115:212–8.CrossRef Hellsten C, Sjostrom K, Lindqvist PG. A 2-year follow-up study of anxiety and depression in women referred for colposcopy after an abnormal cervical smear. BJOG. 2008;115:212–8.CrossRef
10.
Zurück zum Zitat Idestrom M, Milsom I, Andersson-Ellstrom A. Women’s experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand. 2003;82:756–61.PubMed Idestrom M, Milsom I, Andersson-Ellstrom A. Women’s experience of coping with a positive Pap smear: a register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand. 2003;82:756–61.PubMed
11.
Zurück zum Zitat Korfage IJ, Van Ballegooijen M, Huveneers H, Essink-Bot ML. Anxiety and borderline PAP smear results. Eur J Cancer. 2010;46:134–41.CrossRef Korfage IJ, Van Ballegooijen M, Huveneers H, Essink-Bot ML. Anxiety and borderline PAP smear results. Eur J Cancer. 2010;46:134–41.CrossRef
12.
Zurück zum Zitat Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol. 1991;165:658–62.CrossRef Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol. 1991;165:658–62.CrossRef
13.
Zurück zum Zitat Wilkinson C, Jones JM, McBride J. Anxiety caused by abnormal result of cervical smear test: a controlled trial. BMJ. 1990;300:440.CrossRef Wilkinson C, Jones JM, McBride J. Anxiety caused by abnormal result of cervical smear test: a controlled trial. BMJ. 1990;300:440.CrossRef
14.
Zurück zum Zitat Goldsmith MR, Bankhead CR, Austoker J. Synthesizing quantitative and qualitative research in evidence-based patient information. J Epidemiological Community Health. 2007;61(3):262–70.CrossRef Goldsmith MR, Bankhead CR, Austoker J. Synthesizing quantitative and qualitative research in evidence-based patient information. J Epidemiological Community Health. 2007;61(3):262–70.CrossRef
16.
Zurück zum Zitat Hirai K, Harada K, Seki A, Nagatsuka M, Arai H, Hazama A, Ishikawa Y, Hamashima C, Saito H, Shibuya D. Structural equation modeling for implementation intentions, cancer worry, and stages of mammography adoption. Psycho-oncology. 2013;22(10):2339–46.CrossRef Hirai K, Harada K, Seki A, Nagatsuka M, Arai H, Hazama A, Ishikawa Y, Hamashima C, Saito H, Shibuya D. Structural equation modeling for implementation intentions, cancer worry, and stages of mammography adoption. Psycho-oncology. 2013;22(10):2339–46.CrossRef
17.
Zurück zum Zitat Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psycho-oncology. 2005;14(7):517–34.CrossRef Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psycho-oncology. 2005;14(7):517–34.CrossRef
18.
Zurück zum Zitat Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–32.CrossRef Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726–32.CrossRef
19.
Zurück zum Zitat Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA; PAFS Consensus Group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA; PAFS Consensus Group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239.
20.
Zurück zum Zitat Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–9.CrossRef Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–9.CrossRef
21.
Zurück zum Zitat Seki A, Hirai K, Nagatsuka M, Harada K, Arai K, Hazama A, Ishikawa Y, Hamashima C, Saito H, Shibuya D. Measurement of the attitude for breast cancer screening (in Japanese). Kousei-No-Shihyo. 2011;58(2):14–22. Seki A, Hirai K, Nagatsuka M, Harada K, Arai K, Hazama A, Ishikawa Y, Hamashima C, Saito H, Shibuya D. Measurement of the attitude for breast cancer screening (in Japanese). Kousei-No-Shihyo. 2011;58(2):14–22.
22.
Zurück zum Zitat Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol. 1991;10:259–67.CrossRef Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol. 1991;10:259–67.CrossRef
23.
Zurück zum Zitat Sakurai K, Nishi A, Kondo K, Yanagida K, Kawakami N. Screening performance of K6/K10 and other screening instruments for mood and anxiety disorders in Japan. Psychiatry Clin Neurosci. 2011;65:434–41.CrossRef Sakurai K, Nishi A, Kondo K, Yanagida K, Kawakami N. Screening performance of K6/K10 and other screening instruments for mood and anxiety disorders in Japan. Psychiatry Clin Neurosci. 2011;65:434–41.CrossRef
24.
Zurück zum Zitat Kessler RC, Green JG, Gruber MJ, Sampson NA, Bromet E, Cuitan M, Furukawa TA, Gureje O, Hinkov H, Hu CY, Lara C, Lee S, Mneimneh Z, Myer L, Oakley-Browne M, Posada-Villa J, Sagar R, Viana MC, Zaslavsky AM. Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. Int J Methods Psychiatr Res. 2010;19(Suppl 1):4–22.CrossRef Kessler RC, Green JG, Gruber MJ, Sampson NA, Bromet E, Cuitan M, Furukawa TA, Gureje O, Hinkov H, Hu CY, Lara C, Lee S, Mneimneh Z, Myer L, Oakley-Browne M, Posada-Villa J, Sagar R, Viana MC, Zaslavsky AM. Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. Int J Methods Psychiatr Res. 2010;19(Suppl 1):4–22.CrossRef
25.
Zurück zum Zitat Togari T, Yamazaki Y, Koide S, Miyata A. Reliability and validity of the modified Perceived Health Competence Scale (PHCS) Japanese version. Nippon Koshu Eisei Zasshi. 2006;53(1):51–7.PubMed Togari T, Yamazaki Y, Koide S, Miyata A. Reliability and validity of the modified Perceived Health Competence Scale (PHCS) Japanese version. Nippon Koshu Eisei Zasshi. 2006;53(1):51–7.PubMed
26.
Zurück zum Zitat Smith MS, Wallston KA, Smith CA. The development and validation of the Perceived Health Competence Scale. Health Educ Res. 1995;10:51–64.CrossRef Smith MS, Wallston KA, Smith CA. The development and validation of the Perceived Health Competence Scale. Health Educ Res. 1995;10:51–64.CrossRef
27.
Zurück zum Zitat Karasz A, McKee M, Roybal K. Women’s experiences of abnormal cervical cytology: illness representations, care processes, and outcomes. Ann Fam Med. 2003;1(4):196–202.CrossRef Karasz A, McKee M, Roybal K. Women’s experiences of abnormal cervical cytology: illness representations, care processes, and outcomes. Ann Fam Med. 2003;1(4):196–202.CrossRef
28.
Zurück zum Zitat Forss A, Tishelman C, Widmark C. Women’s experiences of cervical cellular changes: an unintentional transition from health to liminality? Sociol Health Illn. 2004;26(3):306–25.CrossRef Forss A, Tishelman C, Widmark C. Women’s experiences of cervical cellular changes: an unintentional transition from health to liminality? Sociol Health Illn. 2004;26(3):306–25.CrossRef
Metadaten
Titel
Alleviating psychological distress associated with a positive cervical cancer screening result: a randomized control trial
verfasst von
Yukari Isaka
Ai Hori
Rie Tanaka
Masao Ichikawa
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Women's Health / Ausgabe 1/2021
Elektronische ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-021-01207-6

Weitere Artikel der Ausgabe 1/2021

BMC Women's Health 1/2021 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.